621 related articles for article (PubMed ID: 31207390)
1. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
2. Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease.
Velásquez E; Szeitz B; Gil J; Rodriguez J; Palkovits M; Renner É; Hortobágyi T; Döme P; Nogueira FC; Marko-Varga G; Domont GB; Rezeli M
Front Immunol; 2021; 12():750665. PubMed ID: 34712240
[TBL] [Abstract][Full Text] [Related]
3. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
[TBL] [Abstract][Full Text] [Related]
4. Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities.
de Flores R; Das SR; Xie L; Wisse LEM; Lyu X; Shah P; Yushkevich PA; Wolk DA
J Neurosci; 2022 Mar; 42(10):2131-2141. PubMed ID: 35086906
[TBL] [Abstract][Full Text] [Related]
5. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
6. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
7. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of different tau sites during progression of Alzheimer's disease.
Neddens J; Temmel M; Flunkert S; Kerschbaumer B; Hoeller C; Loeffler T; Niederkofler V; Daum G; Attems J; Hutter-Paier B
Acta Neuropathol Commun; 2018 Jun; 6(1):52. PubMed ID: 29958544
[TBL] [Abstract][Full Text] [Related]
10. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
Merlini M; Wanner D; Nitsch RM
Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
[TBL] [Abstract][Full Text] [Related]
13. Regional mosaic genomic heterogeneity in the elderly and in Alzheimer's disease as a correlate of neuronal vulnerability.
Arendt T; Brückner MK; Lösche A
Acta Neuropathol; 2015 Oct; 130(4):501-10. PubMed ID: 26298468
[TBL] [Abstract][Full Text] [Related]
14. Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology.
Stratmann K; Heinsen H; Korf HW; Del Turco D; Ghebremedhin E; Seidel K; Bouzrou M; Grinberg LT; Bohl J; Wharton SB; den Dunnen W; Rüb U
Brain Pathol; 2016 May; 26(3):371-86. PubMed ID: 26193084
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease.
Ferrer I; Andrés-Benito P; Ausín K; Pamplona R; Del Rio JA; Fernández-Irigoyen J; Santamaría E
Brain Pathol; 2021 Nov; 31(6):e12996. PubMed ID: 34218486
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
[TBL] [Abstract][Full Text] [Related]
17. The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome.
Davidson YS; Robinson A; Prasher VP; Mann DMA
Acta Neuropathol Commun; 2018 Jul; 6(1):56. PubMed ID: 29973279
[TBL] [Abstract][Full Text] [Related]
18. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.
Kurbatskaya K; Phillips EC; Croft CL; Dentoni G; Hughes MM; Wade MA; Al-Sarraj S; Troakes C; O'Neill MJ; Perez-Nievas BG; Hanger DP; Noble W
Acta Neuropathol Commun; 2016 Mar; 4():34. PubMed ID: 27036949
[TBL] [Abstract][Full Text] [Related]
20. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]